- Home
- DXLG vs DXR Comparison
DXLG vs DXR Comparison
Compare DXLG & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXLG
- DXR
- Stock Information
- Founded
- DXLG 1976
- DXR 1970
- Country
- DXLG United States
- DXR United States
- Employees
- DXLG N/A
- DXR N/A
- Industry
- DXLG Clothing/Shoe/Accessory Stores
- DXR Medical/Dental Instruments
- Sector
- DXLG Consumer Discretionary
- DXR Health Care
- Exchange
- DXLG Nasdaq
- DXR Nasdaq
- Market Cap
- DXLG 55.4M
- DXR 46.9M
- IPO Year
- DXLG 1987
- DXR N/A
- Fundamental
- Price
- DXLG $1.17
- DXR $13.50
- Analyst Decision
- DXLG Strong Buy
- DXR Strong Buy
- Analyst Count
- DXLG 1
- DXR 1
- Target Price
- DXLG $2.50
- DXR $25.00
- AVG Volume (30 Days)
- DXLG 73.2K
- DXR 5.1K
- Earning Date
- DXLG 11-21-2025
- DXR 01-01-0001
- Dividend Yield
- DXLG N/A
- DXR N/A
- EPS Growth
- DXLG N/A
- DXR 3.46
- EPS
- DXLG N/A
- DXR 0.36
- Revenue
- DXLG $447,744,000.00
- DXR $66,306.00
- Revenue This Year
- DXLG N/A
- DXR N/A
- Revenue Next Year
- DXLG $4.93
- DXR N/A
- P/E Ratio
- DXLG N/A
- DXR $38.30
- Revenue Growth
- DXLG N/A
- DXR N/A
- 52 Week Low
- DXLG $0.90
- DXR $6.55
- 52 Week High
- DXLG $3.10
- DXR $14.00
- Technical
- Relative Strength Index (RSI)
- DXLG 36.16
- DXR 66.65
- Support Level
- DXLG $1.29
- DXR $13.39
- Resistance Level
- DXLG $1.31
- DXR $14.00
- Average True Range (ATR)
- DXLG 0.07
- DXR 0.50
- MACD
- DXLG -0.02
- DXR 0.13
- Stochastic Oscillator
- DXLG 3.34
- DXR 80.93
About DXLG Destination XL Group Inc.
Destination XL Group Inc is a retailer of branded and Tall men's clothing and shoes in the United States. It also sells products across the world. The company sells its products under the trade names Destination XL, DXL, DXL Men's Apparel, DXL outlets, Casual Male XL, and Casual Male XL outlets. The company has two principal operating segments: Store, and Direct business.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.